Promising cell therapy offers hope for relapsed or refractory T-cell leukemia
Antileukemic activity of anti-CD7 PEBL-CAR T cells. Credit: Natural medicine (2024). DOI: 10.1038/s41591-024-03228-8 A new cell therapy, targeting CD7 in ...
Antileukemic activity of anti-CD7 PEBL-CAR T cells. Credit: Natural medicine (2024). DOI: 10.1038/s41591-024-03228-8 A new cell therapy, targeting CD7 in ...
Researchers from the Pritzker School of Molecular Engineering (PME) at the University of Chicago and UChicago Medicine, including Asst. Professor ...
The brain of a 7-day-old fruit fly with Tau expressed in a neural circuit used by the fly in olfactory ...
Microparticles containing the immunomodulatory compound CCL2. Credit: Julie Kobyra, University of Pittsburgh Targeting the immune system could prevent or treat ...
Tumors in a section of untreated muscle-invasive bladder cancer (left) compared with a section treated with rosiglitazone and trametinib showing ...
Model of MERTK mechanisms for regulation of the TGFβ core fibrotic pathway in various organs. Credit: Scientific translational medicine (2024). ...
Schematic of pesticide detoxification strategy using HMI and HMI characterization. Credit: Nature and sustainability (2024). DOI: 10.1038/s41893-024-01432-5 Scientists may have ...
ER-mediated transcriptional resistance to BD inhibition. Credit: Nature Structural and Molecular Biology (2024). DOI: 10.1038/s41594-024-01384-6 A decade ago, hopes were ...
MuSyC dose response surface for the combination of C10 and venetoclax in HL60 (left), MV4:11 (middle), and NOMO-1 (right) cells. ...
Modified peptide derived from natural CART peptide. After repeated administration to mice with obesity and prediabetes, the mice began to ...
© 2023 Manhattan Tribune -By Millennium Press
© 2023 Manhattan Tribune -By Millennium Press